These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 814703
1. Lipid metabolism of the arterial wall in thromboangiitis obliterans (Buerger's disease). Horsch AK. Virchows Arch A Pathol Anat Histol; 1975 Dec 31; 369(2):123-30. PubMed ID: 814703 [Abstract] [Full Text] [Related]
9. [Proceedings: Incorporation of 1-14C-oleic acid in subcellular fractions or normal and atherosclerotic human femoral arteries in vitro]. Horsch AK, Day AJ. MMW Munch Med Wochenschr; 1974 May 31; 116(22):1111-2. PubMed ID: 4211595 [No Abstract] [Full Text] [Related]
10. Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture. Sato T, Tamai H, Kobayashi M, Yamamoto K, Komori K. Cardiovasc Pathol; 2011 May 31; 20(5):266-71. PubMed ID: 20708412 [Abstract] [Full Text] [Related]
12. Chemical composition and physical state of lipid deposits in atherosclerosis. Lundberg B. Atherosclerosis; 1985 Jul 31; 56(1):93-110. PubMed ID: 4026939 [Abstract] [Full Text] [Related]
13. [Serum lipids and lipoproteins in peripheral vascular disease]. Umemoto T. Nihon Geka Gakkai Zasshi; 1985 Jan 31; 86(1):84-97. PubMed ID: 3974570 [Abstract] [Full Text] [Related]
14. Incorporation of (14C)oleic acid into lipid by foam cells and by other fractions separated from rabbit atherosclerotic lesions. Day AJ, Tume RK. Atherosclerosis; 1970 Jan 31; 11(2):291-9. PubMed ID: 5527517 [No Abstract] [Full Text] [Related]
15. Thromboangiitis obliterans: classic and new morphological features. Kurata A, Franke FE, Machinami R, Schulz A. Virchows Arch; 2000 Jan 31; 436(1):59-67. PubMed ID: 10664163 [Abstract] [Full Text] [Related]
16. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans. Idei N, Nishioka K, Soga J, Hidaka T, Hata T, Fujii Y, Fujimura N, Maruhashi T, Mikami S, Teragawa H, Kihara Y, Noma K, Chayama K, Higashi Y. Hypertension; 2011 Jan 31; 57(1):70-8. PubMed ID: 21115876 [Abstract] [Full Text] [Related]
17. Reduced circulating endothelial progenitor cells in thromboangiitis obliterans (Buerger's disease). Park HS, Cho KH, Kim KL, Kim DK, Lee T. Vasc Med; 2013 Dec 31; 18(6):331-9. PubMed ID: 24292638 [Abstract] [Full Text] [Related]
18. Different immunophenotypes in Buerger's disease. Kurata A, Machinami R, Schulz A, Fukayama M, Franke FE. Pathol Int; 2003 Sep 31; 53(9):608-15. PubMed ID: 14507318 [Abstract] [Full Text] [Related]
19. Comparative studies on fatty acid synthesis in atherosclerotic and hypoxic human aorta. Filipovic I, Rutemoller M. Atherosclerosis; 1976 Sep 31; 24(3):457-69. PubMed ID: 184799 [Abstract] [Full Text] [Related]
20. Lipid metabolism in perfused human and dog coronary arteries. Sarma JS, Tillmanns H, Ikeda S, Grenier A, Colby E, Bing RJ. Am J Cardiol; 1975 Apr 31; 35(4):579-87. PubMed ID: 164113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]